biological source
human
recombinant
expressed in Saccharomyces cerevisiae
form
liquid
specific activity
≥1.0 units/pmol enzyme
secondary activity
≥100 units/mg protein (Reductase activity)
concentration
≥10 mg/mL protein (Bradford), 1 pmol/μL (P450)
UniProt accession no.
application(s)
cell analysis
shipped in
dry ice
storage temp.
−70°C
Quality Level
Gene Information
human ... CYP2C19(1577)
正在寻找类似产品? 访问 产品对比指南
General description
Microsome contents of CYP2C19 human and yeast CYP-reductase expressed in Saccharomyces cerevisiae.
Application
Recombinant cytochrome P450, isozyme 2C19, (CYP2C19) may be used in toxicity and drug metabolism research to identify its specificity and activity versus xenobiotic and endogenous compounds. Recombinant cytochrome P450, isozyme 2C19, may be used separately or as a component of a P450 isozyme panel to identify and characterize natural and synthetic selective inhibitors that affect the metabolism of toxic compounds or therapeutic drugs such as to facitinib, clopidogrel and voriconazole.
Physical form
50 mM Tris (pH 7.4), 1 mM EDTA, 20% glycerol
Other Notes
For more more information visit our drug metabolism resources for Cytochrome P450 microsome preparations.
P450 Activity: One unit will oxidize 1 picomole of diclofenac per minute at pH 7.4 at 28 °C.
Reductase Activity: One unit will reduce 1 nanomole of cytochrome C per minute in the presence of NADPH at pH 7.4 at 28 °C.
Reductase Activity: One unit will reduce 1 nanomole of cytochrome C per minute in the presence of NADPH at pH 7.4 at 28 °C.
存储类别
12 - Non Combustible Liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持